ATE311869T1 - Zubereitungen für die behandlung und verhinderung von kardiovaskulären erkrankungen - Google Patents

Zubereitungen für die behandlung und verhinderung von kardiovaskulären erkrankungen

Info

Publication number
ATE311869T1
ATE311869T1 AT99952559T AT99952559T ATE311869T1 AT E311869 T1 ATE311869 T1 AT E311869T1 AT 99952559 T AT99952559 T AT 99952559T AT 99952559 T AT99952559 T AT 99952559T AT E311869 T1 ATE311869 T1 AT E311869T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
cardiovascular diseases
component
preparations
Prior art date
Application number
AT99952559T
Other languages
English (en)
Inventor
Herwig Buchholz
Jerzy D Meduski
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE311869T1 publication Critical patent/ATE311869T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT99952559T 1998-10-30 1999-10-13 Zubereitungen für die behandlung und verhinderung von kardiovaskulären erkrankungen ATE311869T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10620598P 1998-10-30 1998-10-30
PCT/EP1999/007689 WO2000025764A2 (en) 1998-10-30 1999-10-13 Compositions for the treatment and prevention of cardiovascular diseases

Publications (1)

Publication Number Publication Date
ATE311869T1 true ATE311869T1 (de) 2005-12-15

Family

ID=22310103

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99952559T ATE311869T1 (de) 1998-10-30 1999-10-13 Zubereitungen für die behandlung und verhinderung von kardiovaskulären erkrankungen

Country Status (11)

Country Link
EP (1) EP1124548B1 (de)
JP (2) JP5220968B2 (de)
KR (1) KR100711339B1 (de)
CN (1) CN1214788C (de)
AT (1) ATE311869T1 (de)
AU (1) AU6470999A (de)
BR (1) BR9914815A (de)
CA (1) CA2348445C (de)
DE (1) DE69928826T2 (de)
ES (1) ES2255309T3 (de)
WO (1) WO2000025764A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
AU7566601A (en) * 2000-06-02 2001-12-11 Merck Patent Gmbh Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
BE1015608A6 (fr) * 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
NZ532666A (en) * 2004-04-30 2008-03-28 Ind Res Ltd A method of promoting angiogenesis, or treating a disease or disorder where it is desirable to promote angiogenesis, comprising administering a therapeutically effective amount of an angiogenesis promoting extract of the skin of a citrus fruit to a non-human animal
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
MX2007013486A (es) 2005-04-27 2008-03-14 Jallal Messadek Combinaciones de insulinas.
US20080255098A1 (en) * 2007-04-13 2008-10-16 Robert Dunn Compositions and Methods for Treatment of Psychiatric Disorders
HUP2000298A1 (hu) * 2020-09-11 2022-03-28 Laszlo Gyulai Vírusfertõzés, elõnyösen SARS-COV-2 és IBV koronavírusok fertõzésének visszaszorítására alkalmazható táplálék-kiegészítõ vagy gyógyászati vagy gyógyszerkészítmény és formulálásuk

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2583640A1 (fr) * 1985-06-24 1986-12-26 Berdal Pascal Compositions pharmaceutiques a visee vasculotrope et antisclereuse
MC2041A1 (fr) * 1988-06-24 1990-05-30 Johannes Cornelius Str Andries Agents anti-atherogenic
JPH08224071A (ja) * 1995-02-20 1996-09-03 Dot Onotsukusu Kk 芳香性果汁とその製造法
US5626884A (en) * 1995-08-18 1997-05-06 Lockett; Curtis G. Treatment of sickle cell disease
WO1998018491A1 (en) * 1996-10-28 1998-05-07 BURGSTINER, Jacqueline, Cook Methods and compositions for dietary supplementation
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
JPH10203949A (ja) * 1997-01-27 1998-08-04 Narisu Keshohin:Kk 化粧料
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods

Also Published As

Publication number Publication date
KR20010080339A (ko) 2001-08-22
BR9914815A (pt) 2001-07-03
WO2000025764A3 (en) 2000-07-13
CN1426301A (zh) 2003-06-25
WO2000025764A2 (en) 2000-05-11
DE69928826T2 (de) 2006-09-07
AU6470999A (en) 2000-05-22
ES2255309T3 (es) 2006-06-16
CN1214788C (zh) 2005-08-17
CA2348445C (en) 2009-12-15
JP2011042673A (ja) 2011-03-03
JP5220968B2 (ja) 2013-06-26
CA2348445A1 (en) 2000-05-11
EP1124548A2 (de) 2001-08-22
DE69928826D1 (de) 2006-01-12
EP1124548B1 (de) 2005-12-07
JP2002528488A (ja) 2002-09-03
KR100711339B1 (ko) 2007-04-27

Similar Documents

Publication Publication Date Title
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
MY116896A (en) Taste of active pharmaceutical ingredients.
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
CA2348390A1 (en) Compositions for the treatment and prevention of neurological and pathopsychological diseases
HUP9600116A2 (en) Fungicidal compositions containing benzophenone and process for preparation of the active ingredients and method for the control of fungi.
ITFI930083A0 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
ATE311869T1 (de) Zubereitungen für die behandlung und verhinderung von kardiovaskulären erkrankungen
TW268937B (de)
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
SE9802937D0 (sv) Novel compounds
EA200000240A1 (ru) Соединения, препятствующие эффекту раннего превращения лекарственных средств
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
HUP0200679A2 (en) Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
DE69905489T2 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
ITMI941696A0 (it) 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono
IT8922275A0 (it) Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITRM950421A0 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare, procedimento per la loro preaparazione e composizioni farmaceutiche che li contengono.
ITFI930007A0 (it) Tiodiazepine, loro processidi preparazione e composizioni farmaceuti- che che le contengono.
ITRM940715A0 (it) Nuovi 1,5 derivati di 7a-metilperidroinden-3a-oli, attivi sul sistema cardiovascolare, procedimenti per la loro preparazione e composizione farmaceutiche che li contengono
DE69838981D1 (de) Komponente und Zusammensetzungen zur Verabreichung von Wirkstoffen
RU97102805A (ru) Повидло

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties